When making changes after the product is on the market, potential risk is used t...
✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.
When making changes after the product is on the market, potential risk is used to determine whether FDA approval is needed. A CBE-30 filing can be used for changes that are not high risk. Fill-in the following 2 blanks:
If after submitting a CBE-30 to the FDA for changes to a product or process, a company has not heard any concerns from the FDA after ___A___ days, then the company is allowed to____B_____
Want instant access to all verified answers on moodle.earlham.edu?
Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!